Intellia Therapeutics Inc.

Finance

Intellia Therapeutics Inc. (NASDAQ:NTLA) Stock: Worth Taking a Bite?

Intellia Therapeutics Inc. (NASDAQ:NTLA) shares fell to a low of $84.21 before closing at $88.00. Intraday shares traded counted 1.73 million, which was -39.8% lower

Industry

Is Intellia Therapeutics Inc. (NASDAQ:NTLA) Worth A Bite? NTLA 200 SMA stands at 52.97%

Intellia Therapeutics Inc. (NASDAQ:NTLA) has a beta of 2.02. The stock’s Relative Strength Index (RSI) is 62.66, with weekly volatility at 7.30% and ATR at

Markets

Risks You Need To Know Before Getting in Intellia Therapeutics Inc. (NASDAQ:NTLA)

Intellia Therapeutics Inc. (NASDAQ:NTLA) has a beta of 2.05. The stock’s Relative Strength Index (RSI) is 54.67, with weekly volatility at 6.97% and ATR at

Finance

Are Intellia Therapeutics Inc. (NASDAQ:NTLA) Prospects Worsening?

Intellia Therapeutics Inc. (NASDAQ:NTLA) has a beta of 2.07. The stock’s Relative Strength Index (RSI) is 50.86, with weekly volatility at 5.83% and ATR at

Tag: Intellia Therapeutics Inc.